Cooley: Lycia Therapeutics Announces Upsized $317.5 Million IPO
October 24, 2026
October 24, 2026
PALO ALTO, California, Oct. 24 -- Cooley, a law firm, issued the following news release:
* * *
Lycia Therapeutics Announces Upsized $317.5 Million IPO
San Diego October 22, 2026
Cooley advised the underwriters of Lycia Therapeutics, a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, in connection with Lycia Therapeutics' upsized . . .
* * *
Lycia Therapeutics Announces Upsized $317.5 Million IPO
San Diego October 22, 2026
Cooley advised the underwriters of Lycia Therapeutics, a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, in connection with Lycia Therapeutics' upsized . . .